PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Naratriptan hydrochloride - Migraine (acute)
PAD Profile : Naratriptan hydrochloride - Migraine (acute)
Keywords :
Triptans, acute migraine, migraine treatment
Brand Names Include :
Naramig
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Sumatriptan succinate
- Zolmitriptan
- Frovatriptan
- Almotriptan
- Eletriptan
- Rizatriptan
- Melatonin
- Rimegepant
- Analgesics with anti-emetics
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
02 March 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
UPDATED: The PCN recommends that sumatriptan, zolmitriptan, rizatriptan and naratriptan should be considered as first line triptans where clinically appropriate and should be prescribed generically.
Associated BNF Codes
04. Central Nervous System
04.07.04. Antimigraine drugs